Telomir Pharmaceuticals, Inc. (TELO) Technical Analysis
Technical Sentiment
Overall ConsensusSell
14Bearish
3Neutral
5Bullish
Technical Analysis ConsensusBuy
2Bearish
3Neutral
5Bullish
Moving Average ConsensusStrong Sell
12Bearish
0Neutral
0Bullish
1 Day timeframe · Data as of Oct 30, 2026
- Telomir Pharmaceuticals, Inc.’s (TELO) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Telomir Pharmaceuticals, Inc. is a Buy.
- Telomir Pharmaceuticals, Inc.’s (TELO) 20-Day exponential moving average is $1.04, while Telomir Pharmaceuticals, Inc.’s (TELO) share price is $0.94, making it a Sell.
- Telomir Pharmaceuticals, Inc.’s (TELO) 50-Day exponential moving average is $1.10, while Telomir Pharmaceuticals, Inc.’s (TELO) share price is $0.94, making it a Sell.
Telomir Pharmaceuticals, Inc. (TELO) Pivot Points
1 Day timeframe · Data as of Oct 30, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 0.90 | 0.93 | 0.94 | 0.98 | 0.99 | 1.03 | 1.04 |
| Fibonacci | 0.93 | 0.95 | 0.96 | 0.98 | 1.00 | 1.01 | 1.03 |
Telomir Pharmaceuticals, Inc. (TELO) Moving Averages
1 Day timeframe · Data as of Oct 30, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 0.99Sell | 0.98Sell |
| MA10 | 1.00Sell | 1.00Sell |
| MA20 | 1.06Sell | 1.04Sell |
| MA50 | 1.13Sell | 1.10Sell |
| MA100 | 1.16Sell | 1.15Sell |
| MA200 | 1.22Sell | 1.22Sell |
- Telomir Pharmaceuticals, Inc.’s (TELO) 10-Day exponential moving average is $1.00, while Telomir Pharmaceuticals, Inc.’s (TELO) share price is $0.94, making it a Sell.
- Telomir Pharmaceuticals, Inc.’s (TELO) 100-Day exponential moving average is $1.15, while Telomir Pharmaceuticals, Inc.’s (TELO) share price is $0.94, making it a Sell.
- Telomir Pharmaceuticals, Inc.’s (TELO) stock price is $0.94 and Telomir Pharmaceuticals, Inc.’s (TELO) 50-day simple moving average is $1.13, creating a Sell signal.
- Telomir Pharmaceuticals, Inc.’s (TELO) stock price is $0.94 and Telomir Pharmaceuticals, Inc.’s (TELO) 100-day simple moving average is $1.16, creating a Sell signal.
- Telomir Pharmaceuticals, Inc.’s (TELO) stock price is $0.94 and Telomir Pharmaceuticals, Inc.’s (TELO) 200-day simple moving average is $1.22, creating a Sell signal.
Telomir Pharmaceuticals, Inc. (TELO) Technical Indicators
1 Day timeframe · Data as of Oct 30, 2026
| Name | Value | Implied Action |
|---|---|---|
| RSI (14) | 29.32 | Buy |
| STOCH (9,6) | 27.66 | Neutral |
| STOCHRSI (14) | 19.14 | Buy |
| MACD (12,26) | -0.05 | Buy |
| ADX (14) | 28.51 | Neutral |
| Williams %R | -63.41 | Buy |
| CCI (14) | -156.07 | Buy |
| ATR (14) | 0.08 | - |
| Ultimate Oscillator | 43.12 | Neutral |
| ROC | -14.55 | Sell |
- Telomir Pharmaceuticals, Inc.’s (TELO) Relative Strength Index (RSI) is 29.32, creating a Buy signal.
- Telomir Pharmaceuticals, Inc.’s (TELO) Trend Strength Indicator (ADX) is 28.51, creating a Neutral signal.
- Telomir Pharmaceuticals, Inc.’s (TELO) Commodity Channel Index (CCI) is -156.07, creating a Buy signal.
- Telomir Pharmaceuticals, Inc.’s (TELO) Price Rate of Change (ROC) is -14.55, creating a Sell signal.
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is TELO a Buy, Hold, or Sell?
Based on TELO’s technical indicators on the 1-day timeframe as of Oct 30, 2026, TELO is a Sell.
What is TELO’s RSI (14)?
TELO’s RSI (14) is 29.32, which suggests TELO is a Buy.
What is TELO’s MACD?
TELO’s MACD is -0.05, which suggests TELO is a Buy.
What is TELO’s 5-day moving average?
TELO’s 5-day moving average is 0.99, which suggests TELO is a Sell.
What is TELO’s 20-day moving average?
TELO 20-day moving average is 1.06, which suggests TELO is a Sell.
What is TELO’s 50-day moving average?
TELO’s 50-day moving average is 1.13, which suggests TELO is a Sell.
What is TELO’s 200-day moving average?
TELO’s 200-day moving average is 1.22, which suggests TELO is a Sell.
What is TELO’s Williams % R (14)?
TELO’s Williams % R (14) is -63.41, which suggests TELO is a Buy.
What is TELO’s CCI (14)?
TELO’s CCI (14) is -156.07, which suggests TELO is a Buy.
